LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)

This study has been completed.

First Received: September 20, 2007 Last Updated: February 14, 2008 History of Changes

Sponsored by:	AstraZeneca
Information provided by:	AstraZeneca
ClinicalTrials.gov Identifier:	NCT00567619

Purpose

Evaluate burden of disease in Patients with newly occurred upper GI symptoms related to GERD (symptom frequency & severity, QoL, lifestyle modifications, self-medication) - baseline data according to GERD impact scale presenting to specialists, especially internists

Evaluate effect of treatment with a acid suppressive therapy on these parameters: looking for improvement of symptom burden and quality of life according to the GERD impact sca

Condition
GERD

U.S. FDA Resources

Study Type:	Observational
Study Design:	Prospective
Official Title:	LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)

Further study details as provided by AstraZeneca:

Estimated Enrollment:	900
Study Start Date:	July 2007

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients with newly occured upper GI symptoms related to GERD

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00567619

Locations

Austria
Research Site
Vienna, Austria

Sponsors and Collaborators

AstraZeneca

Investigators

Study Chair:

Not required for Study

Not required for this study

More Information

No publications provided

Study ID Numbers:	NIS-GAT-NEX-2007/1
Study First Received:	September 20, 2007
Last Updated:	February 14, 2008
ClinicalTrials.gov Identifier:	NCT00567619 History of Changes
Health Authority:	Not required for this study:

Keywords provided by AstraZeneca:

GERD
NIS

Study placed in the following topic categories:

Deglutition Disorders
Esophageal Motility Disorders
Digestive System Diseases
Esophageal Disorder

Gastrointestinal Diseases
Esophageal Diseases
Gastroesophageal Reflux

Additional relevant MeSH terms:

Deglutition Disorders
Esophageal Motility Disorders
Digestive System Diseases

Gastrointestinal Diseases
Esophageal Diseases
Gastroesophageal Reflux

ClinicalTrials.gov processed this record on May 07, 2009